The proposed CDU-CRECD Mentored Postdoctoral Training in Translational Research and Biomedical Informatics Program at Charles R. Drew University (CDU) is a mentored clinical research and career development program designed to develop a diverse cadre of clinical and translational investigators who conduct innovative research on the underlying causes of diseases that disproportionately impact minority populations in the United States (e.g., cancer, drug use and addiction, and mental health/psychiatric disorders), and to foster and facilitate professional development activities in clinical and translational sciences. Over the proposed 5-year program period, the CDU-CRECD Program will accept a total of 12 minority postdoctoral trainees at the junior faculty level at CDU. Phase I is comprised of two years of structured mentoring and support for earning a Master of Public Health (MPH) in Urban Health Disparities with a dual focus on the fields of Biomedical Informatics and Community Participatory Clinical Translational Research. Phase II is comprised of a clinical/translational research project to continue working toward establishing their own independent research program as clinical research scientists leading to applications for individual mentored career development (K) or research grant (R series) awards. The CRECD Program will be embedded within the existing, extensive clinical research and training infrastructure at CDU, and thus will mutually leverage resources with other CDU research education and career development programs so as to achieve maximal cross-program synergies as well as efficiencies from utilizing already-in-place education and training curricula and related resources germane to the CRECD agenda. The CRECD Program will also carve out a unique niche of training and career development opportunities within the broader CDU science- generating ?critical mass? by (1) focusing exclusively on urban health disparities and mastery of biomedical informatics and community-partnered participatory methods in the research and research training agenda and (2) providing to each trainee an intensive and community-immersive mentoring configuration that includes CDU faculty from both the conventional Academic Career track and the Community Faculty track. This intensive mentoring innovation directly emerges from, and formalizes and systematizes into a signature trainee mentoring configuration, a long and fruitful history of community-engaged research, training, and educational curricula at CDU. As an integrated research training and career development package, this approach is designed to bring social determinants of health to the forefront of molecular and clinical research. Ultimately, the goal is to increase the impact of community-academic partnered research through comprehensive dissemination of research findings so as to encourage and facilitate implementation of evidence-based treatment and prevention practices within health care organizations and the communities most in need of reliable access to high-quality care.

Public Health Relevance

By providing underrepresented junior faculty and postdoctoral scholars the opportunity to earn a Master of Public Health (MPH) in Urban Health Disparities with a dual focus on the fields of Biomedical Informatics and Community Based Participatory Research, followed by intensive research mentoring, training, and career development, this renewal of the CRECD Program at Charles R. Drew University will enhance the diversity of the research workforce, and produce independent clinical and translational investigators who conduct innovative research on the underlying causes of diseases that disproportionately affect minority populations in the United States.

Agency
National Institute of Health (NIH)
Institute
National Institute on Minority Health and Health Disparities (NIMHD)
Type
Education Projects (R25)
Project #
5R25MD007610-08
Application #
9688875
Study Section
Special Emphasis Panel (ZMD1)
Program Officer
Das, Rina
Project Start
2012-09-19
Project End
2022-04-30
Budget Start
2019-05-01
Budget End
2020-04-30
Support Year
8
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Charles R. Drew University of Medicine & Science
Department
Family Medicine
Type
Schools of Medicine
DUNS #
785877408
City
Los Angeles
State
CA
Country
United States
Zip Code
90059
Chung, Seyung S; Dutta, Pranabananda; Austin, David et al. (2018) Combination of resveratrol and 5-flurouracil enhanced anti-telomerase activity and apoptosis by inhibiting STAT3 and Akt signaling pathways in human colorectal cancer cells. Oncotarget 9:32943-32957
Bazargan, Mohsen; Smith, James L; King, Ebony O (2018) Potentially inappropriate medication use among hypertensive older African-American adults. BMC Geriatr 18:238
Del Pino, Homero E; Harawa, Nina T; Liao, Diana et al. (2018) Age and Age Discordance Associations with Condomless Sex Among Men Who Have Sex with Men. AIDS Behav 22:649-657
Bazargan, Mohsen; Smith, James; Yazdanshenas, Hamed et al. (2017) Non-adherence to medication regimens among older African-American adults. BMC Geriatr 17:163
Arshi, Armin; Sharim, Justin; Park, Don Y et al. (2017) Chondrosarcoma of the Osseous Spine: An Analysis of Epidemiology, Patient Outcomes, and Prognostic Factors Using the SEER Registry From 1973 to 2012. Spine (Phila Pa 1976) 42:644-652
Bazargan, Mohsen; Smith, James; Movassaghi, Masoud et al. (2017) Polypharmacy among Underserved Older African American Adults. J Aging Res 2017:6026358
Wu, Yanyuan; Sarkissyan, Marianna; Clayton, Sheilah et al. (2017) Association of Vitamin D3 Level with Breast Cancer Risk and Prognosis in African-American and Hispanic Women. Cancers (Basel) 9:
Chung, Seyung S; Adekoya, Debbie; Enenmoh, Ikechukwu et al. (2017) Salinomycin Abolished STAT3 and STAT1 Interactions and Reduced Telomerase Activity in Colorectal Cancer Cells. Anticancer Res 37:445-453
Wu, Y; Vadgama, J V (2017) Androgen Receptor as a Potential Target for Treatment of Breast Cancer. Int J Cancer Res Mol Mech 3:
Shamie, Arya Nick; Yazdanshenas, Hamed; Johnson, Eric Egan (2017) Long-term safety and efficacy of human bone morphogenetic protein (HBMP) in the treatment of resistant non-unions and failed arthrodesis. J Clin Orthop Trauma 8:59-62

Showing the most recent 10 out of 46 publications